Tectal gliomas are a rare entity mostly showing an indolent clinical course. However, in some cases progression of disease prompts medical treatment. We report a series of 12 consecutive patients diagnosed with tectal glioma at the Bambino Gesù Children's Hospital from 2012 to 2016. Diagnosis was made according to typical radiological features. Mean follow-up was 43 months (4 to 75 months). Symptoms at onset were macrocrania and full fontanelle in congenital cases and headache, vomiting, ataxia, postural instability, short term memory and attention difficulties in older children, suggesting a strong role of hydrocephalus. Mean age at diagnosis was 8 years and girls were three times more frequent than boys. Hydrocephalus was present at the time of the diagnosis virtually in all cases (10/11). In three cases hydrocephalus was congenital but diagnosis of tectal glioma was made 8 years later in one case, due to limited access to MRI imaging at the time of hydrocephalus treatment. Hydrocephalus was treated by endoscopic ventriculostomy in all patients presenting after 2008. We had a major complication in one girl, suffering acute intracranial hypertension with severe outcome 20 months after diagnosis presumably from unexpected ventriculostomy closure. After that, we propose routine positioning of a Rickham ventricular access device in all children with hydrocephalus secondary to tectal gliomas. Three children showed progression of their tectal lesion or gaze disturbances prompting stereotactic needle biopsy to obtain histological diagnosis and start oncological treatment. Surgical resection was never indicated, as large esophytic lesions were not observed in our series.
. 2016 May 30;18(Suppl 3):iii130. doi: 10.1093/neuonc/now078.15
NS-15: NEUROSURGICAL MANAGEMENT OF TECTAL GLIOMAS
Andrea Carai
1, Antonio Marrazzo
2, Vito Andrea dell'Anna
2, Alessandro De Benedictis
1, Raffaella Messina
1, Franco Randi
1, Giovanna Stefania Colafati
3, Antonella Cacchione
2, Evelina Miele
2, Angela Mastronuzzi
2, Carlo Efisio Marras
1
Andrea Carai
1Department of Neurosciences and Neurorehabilitation, Neurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Andrea Carai
Antonio Marrazzo
2Department of Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Antonio Marrazzo
Vito Andrea dell'Anna
2Department of Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Vito Andrea dell'Anna
Alessandro De Benedictis
1Department of Neurosciences and Neurorehabilitation, Neurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Alessandro De Benedictis
Raffaella Messina
1Department of Neurosciences and Neurorehabilitation, Neurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Raffaella Messina
Franco Randi
1Department of Neurosciences and Neurorehabilitation, Neurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Franco Randi
Giovanna Stefania Colafati
3Department of Imaging, Neuroradiology Unit, Rome, Italy
Find articles by Giovanna Stefania Colafati
Antonella Cacchione
2Department of Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Antonella Cacchione
Evelina Miele
2Department of Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Evelina Miele
Angela Mastronuzzi
2Department of Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Angela Mastronuzzi
Carlo Efisio Marras
1Department of Neurosciences and Neurorehabilitation, Neurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy
Find articles by Carlo Efisio Marras
1Department of Neurosciences and Neurorehabilitation, Neurosurgery Unit, Bambino Gesù Children's Hospital, Rome, Italy
2Department of Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
3Department of Imaging, Neuroradiology Unit, Rome, Italy
Issue date 2016 Jun.
© the author(s) 2016. published by oxford university press on behalf of the society for neuro-oncology. all rights reserved. for permissions, please e-mail: journals.permissions@oup.com
PMCID: PMC4903690
